GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aarti Drugs Ltd

Aarti Drugs: GPCB revokes closure order for Sayakha plant; Rs. 10,20,000 penalty levied

REGULATORY ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 01 Aug 2026, 04:34 PM IST  ·  BSE ID: 4da10fa4-2689-42ef-ac9e-9b5661c18178
View Original BSE Filing (PDF)
💡
In Simple Terms
Aarti Drugs can restart its Gujarat plant after the pollution control board lifted a closure order and the company paid a fine.
🤖 AI Summary
  • Gujarat Pollution Control Board revokes closure order for Aarti Drugs' Sayakha plant.
  • Company resumes Amines manufacturing operations following the revocation order.
  • An interim Environmental Damage Compensation of Rs. 10,20,000 was levied.
  • The closure was initially directed due to non-compliances observed on June 20, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Environmental Damage Compensation
Rs. 10,20,000
🏢 How This Affects the Company
📈
Business Impact
The revocation allows the company to resume normal business operations at its Amines manufacturing facility in Sayakha.
💰
Financial Impact
The company incurred an interim Environmental Damage Compensation of Rs. 10,20,000.
⚙️
Operational Impact
Normal operational activities at the Sayakha plant are permitted to continue.
⚠️
Risk Impact
The immediate operational risk associated with the closure direction has been mitigated.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders at this time.
👤
Who Is Affected
All shareholders are indirectly affected by the resolution of operational disruptions.
🔍
Management Signal
Management's prompt action in addressing regulatory concerns and securing operational continuity is demonstrated.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Confirmation of sustained operational compliance at Sayakha plant.
Future environmental compliance reports from GPCB.
any further regulatory actions or directives.
MEDIUM RISK Past non-compliance leading to closure, though order revoked, indicates ongoing regulatory scrutiny.
💡 Investor Takeaway
Aarti Drugs' Sayakha plant operations resume after GPCB revocation. The company paid Rs. 10,20,000 as interim environmental compensation.
⚖️ Strengths & Concerns

✅ Positives

  • Revocation of closure order allows resumption of manufacturing operations.
  • Interim Environmental Damage Compensation is a quantifiable cost of Rs. 10,20,000.

⚠️ Concerns

  • Initial closure was due to observed non-compliances of Water Act and CCA conditions.
  • A penalty of Rs. 10,20,000 was levied as an interim Environmental Damage Compensation.
❓ Frequently Asked Questions
What action did the Gujarat Pollution Control Board (GPCB) take regarding Aarti Drugs' Sayakha plant?
The GPCB revoked its earlier closure direction for the company's Amines manufacturing operations at the Sayakha plant.
What is the financial impact of the GPCB's decision on Aarti Drugs?
Aarti Drugs has paid an interim Environmental Damage Compensation of Rs. 10,20,000 as an interim measure.
What was the reason for the initial closure order by GPCB?
The GPCB issued closure directions due to non-compliances of the Water Act and Consolidated Consents and Authorization conditions observed during an inspection.
When did Aarti Drugs receive the revocation order from GPCB?
Aarti Drugs received the revocation order from the Gujarat Pollution Control Board on July 31, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.